Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Colorcon
Daiichi Sankyo
Deloitte
Fuji
Dow
Queensland Health
Merck

Generated: November 20, 2018

DrugPatentWatch Database Preview

MILRINONE LACTATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for milrinone lactate and what is the scope of milrinone lactate patent protection?

Milrinone lactate is the generic ingredient in six branded drugs marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Hospira Inc, Intl Medicated, Mylan Institutional, West-ward Pharms Int, Renaissance Ssa Llc, B Braun, Baxter Hlthcare, and Sanofi Aventis Us, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for milrinone lactate. Seven suppliers are listed for this compound.

Pharmacology for MILRINONE LACTATE
Medical Subject Heading (MeSH) Categories for MILRINONE LACTATE

US Patents and Regulatory Information for MILRINONE LACTATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 078113-002 May 21, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Farmaceutica MILRINONE LACTATE IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 090038-002 Jan 21, 2010 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira MILRINONE LACTATE milrinone lactate INJECTABLE;INJECTION 075830-001 May 28, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 078113-001 May 21, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 075834-001 May 28, 2002 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gland Pharma Ltd MILRINONE LACTATE milrinone lactate INJECTABLE;INJECTION 077190-001 Oct 31, 2006 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Renaissance Ssa Llc MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 077151-001 Jul 20, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for MILRINONE LACTATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us PRIMACOR milrinone lactate INJECTABLE;INJECTION 019436-001 Dec 31, 1987 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-003 Aug 9, 1994 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-002 Aug 9, 1994 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-001 Aug 9, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Colorcon
Daiichi Sankyo
Deloitte
Fuji
Dow
Queensland Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.